GOG 213: Bevacizumab Plus Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer Last updated on Aug 3, 2026 Previous Primary Treatment of High-Grade Ovarian/Fallopian Tube Carcinoma Next MITO 16B: Bevacizumab Maintenance with Platinum Doublets in Platinum-Sensitive Recurrence
